Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

Researchers analyzed 11 different studies to understand weight outcomes after stopping anti-obesity medications called ...

West Pharmaceutical stock was climbing 19% on Thursday, putting it on track for the strongest single-day percentage increase ...

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But GLP-1s can be an effective reinforcement of diet and exercise.

A Big Chalk Analytics survey of 4,511 U.S. shoppers in spring of 2025 showed that 11.2% of adults are using GLP-1 drugs, and ...

Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...

Longer treatment duration, not having diabetes, and using semaglutide are among the factors linked to better weight reduction over 12 months.